Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters.

PubWeight™: 1.99‹?› | Rank: Top 2%

🔗 View Article (PMID 10585462)

Published in J Biol Chem on December 10, 1999

Authors

G M Daniels1, S G Amara

Author Affiliations

1: Department of Cell Biology, Oregon Health Science University, Portland, Oregon 97201, USA.

Articles citing this

Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism. Proc Natl Acad Sci U S A (2000) 2.27

The dopamine transporter constitutively internalizes and recycles in a protein kinase C-regulated manner in stably transfected PC12 cell lines. J Biol Chem (2003) 2.14

N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux. PLoS Biol (2004) 1.94

Nonclassical, distinct endocytic signals dictate constitutive and PKC-regulated neurotransmitter transporter internalization. Nat Neurosci (2005) 1.68

Generation of an activating Zn(2+) switch in the dopamine transporter: mutation of an intracellular tyrosine constitutively alters the conformational equilibrium of the transport cycle. Proc Natl Acad Sci U S A (2002) 1.68

The N terminus of monoamine transporters is a lever required for the action of amphetamines. J Biol Chem (2010) 1.58

Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesis. Neurosci Biobehav Rev (2009) 1.57

Inhibition of dynamin-dependent endocytosis increases shedding of the amyloid precursor protein ectodomain and reduces generation of amyloid beta protein. BMC Cell Biol (2005) 1.53

Ceftriaxone, a beta-lactam antibiotic, reduces ethanol consumption in alcohol-preferring rats. Alcohol Alcohol (2011) 1.52

Three ubiquitin conjugation sites in the amino terminus of the dopamine transporter mediate protein kinase C-dependent endocytosis of the transporter. Mol Biol Cell (2006) 1.50

A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters. Mol Neurobiol (2009) 1.45

Protein kinase Cbeta is a critical regulator of dopamine transporter trafficking and regulates the behavioral response to amphetamine in mice. J Pharmacol Exp Ther (2008) 1.31

Regulation of monoamine transporters: Role of transporter phosphorylation. Pharmacol Ther (2010) 1.30

Visualization of dopamine transporter trafficking in live neurons by use of fluorescent cocaine analogs. J Neurosci (2009) 1.26

Mechanisms of dopamine transporter regulation in normal and disease states. Trends Pharmacol Sci (2013) 1.25

Dieldrin exposure induces oxidative damage in the mouse nigrostriatal dopamine system. Exp Neurol (2007) 1.24

Analyses of the recycling receptor, FcRn, in live cells reveal novel pathways for lysosomal delivery. Traffic (2009) 1.24

Postendocytic sorting of constitutively internalized dopamine transporter in cell lines and dopaminergic neurons. J Biol Chem (2010) 1.17

Negative regulation of dopamine transporter endocytosis by membrane-proximal N-terminal residues. J Neurosci (2009) 1.16

Lysine 63-linked polyubiquitination of the dopamine transporter requires WW3 and WW4 domains of Nedd4-2 and UBE2D ubiquitin-conjugating enzymes. J Biol Chem (2010) 1.13

Trafficking of dopamine transporters in psychostimulant actions. Semin Cell Dev Biol (2009) 1.11

Differential subcellular distribution of endosomal compartments and the dopamine transporter in dopaminergic neurons. Mol Cell Neurosci (2010) 1.04

Role of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuse. CNS Neurol Disord Drug Targets (2008) 1.03

Protein kinase C-dependent ubiquitination and clathrin-mediated endocytosis of the cationic amino acid transporter CAT-1. J Biol Chem (2011) 1.03

Substrates dissociate dopamine transporter oligomers. J Neurochem (2007) 1.02

Human immunodeficiency virus-1 Tat activates calpain proteases via the ryanodine receptor to enhance surface dopamine transporter levels and increase transporter-specific uptake and Vmax. J Neurosci (2010) 1.01

Regulation of monoamine transporters: influence of psychostimulants and therapeutic antidepressants. AAPS J (2005) 1.01

Proline-directed phosphorylation of the dopamine transporter N-terminal domain. Biochemistry (2009) 0.99

Regulation of neuronal function by protein trafficking: a role for the endosomal pathway. J Physiol (2000) 0.98

Genetic complementation screen identifies a mitogen-activated protein kinase phosphatase, MKP3, as a regulator of dopamine transporter trafficking. Mol Biol Cell (2008) 0.97

Examining the complex regulation and drug-induced plasticity of dopamine release and uptake using voltammetry in brain slices. ACS Chem Neurosci (2013) 0.97

Pgc-1α overexpression downregulates Pitx3 and increases susceptibility to MPTP toxicity associated with decreased Bdnf. PLoS One (2012) 0.96

Rapid substrate-induced down-regulation in function and surface localization of dopamine transporters: rat dorsal striatum versus nucleus accumbens. J Neurochem (2009) 0.96

Internalization and degradation of the glutamate transporter GLT-1 in response to phorbol ester. Neurochem Int (2007) 0.96

HIV-1 Tat protein decreases dopamine transporter cell surface expression and vesicular monoamine transporter-2 function in rat striatal synaptosomes. J Neuroimmune Pharmacol (2012) 0.96

Epitope-tagged dopamine transporter knock-in mice reveal rapid endocytic trafficking and filopodia targeting of the transporter in dopaminergic axons. FASEB J (2012) 0.95

Syntaxin 1A regulates dopamine transporter activity, phosphorylation and surface expression. Neuroscience (2010) 0.95

Creatine uptake in mouse hearts with genetically altered creatine levels. J Mol Cell Cardiol (2008) 0.93

Missense dopamine transporter mutations associate with adult parkinsonism and ADHD. J Clin Invest (2014) 0.92

Effects of N-linked glycosylation on the creatine transporter. Biochem J (2006) 0.92

Protein interacting with C kinase 1 (PICK1) reduces reinsertion rates of interaction partners sorted to Rab11-dependent slow recycling pathway. J Biol Chem (2012) 0.91

Effect of environmental enrichment on methylphenidate-induced locomotion and dopamine transporter dynamics. Behav Brain Res (2011) 0.91

Dopamine transporter endocytic trafficking in striatal dopaminergic neurons: differential dependence on dynamin and the actin cytoskeleton. J Neurosci (2013) 0.89

The PKC inhibitor Ro31-8220 blocks acute amphetamine-induced dopamine overflow in the nucleus accumbens. Neurosci Lett (2009) 0.89

Dopamine transporter trafficking: rapid response on demand. Future Neurol (2010) 0.88

Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease. Pharmacol Rev (2015) 0.88

Flotillins regulate membrane mobility of the dopamine transporter but are not required for its protein kinase C dependent endocytosis. Traffic (2013) 0.87

Rab 11 regulates constitutive dopamine transporter trafficking and function in N2A neuroblastoma cells. Neurosci Lett (2009) 0.87

Monoamine transporters: vulnerable and vital doorkeepers. Prog Mol Biol Transl Sci (2011) 0.87

Palmitoylation controls dopamine transporter kinetics, degradation, and protein kinase C-dependent regulation. J Biol Chem (2010) 0.87

Differential targeting of the dopamine transporter to recycling or degradative pathways during amphetamine- or PKC-regulated endocytosis in dopamine neurons. FASEB J (2013) 0.87

Regulation of dopamine transporter activity by carboxypeptidase E. Mol Brain (2009) 0.85

Membrane-permeable C-terminal dopamine transporter peptides attenuate amphetamine-evoked dopamine release. J Biol Chem (2013) 0.85

Cyclin-dependent kinase 5 inhibitors: inhibition of dopamine transporter activity. Mol Pharmacol (2009) 0.84

Regulation of dynamin 2 and G protein-coupled receptor kinase 2 in rat nucleus accumbens during acute and repeated cocaine administration. Synapse (2009) 0.83

Two allelic isoforms of the serotonin transporter from Schistosoma mansoni display electrogenic transport and high selectivity for serotonin. Eur J Pharmacol (2009) 0.83

Time-of-day differences in dopamine clearance in the rat medial prefrontal cortex and nucleus accumbens. Synapse (2008) 0.82

Visualization of the cocaine-sensitive dopamine transporter with ligand-conjugated quantum dots. ACS Chem Neurosci (2011) 0.82

Translocation of glutamate transporter subtype excitatory amino acid carrier 1 protein in kainic acid-induced rat epilepsy. Am J Pathol (2003) 0.81

Dopamine transporter down-regulation following repeated cocaine: implications for 3,4-methylenedioxymethamphetamine-induced acute effects and long-term neurotoxicity in mice. Br J Pharmacol (2009) 0.81

Melittin stimulates fatty acid release through non-phospholipase-mediated mechanisms and interacts with the dopamine transporter and other membrane-spanning proteins. Eur J Pharmacol (2010) 0.80

Amphetamine activates Rho GTPase signaling to mediate dopamine transporter internalization and acute behavioral effects of amphetamine. Proc Natl Acad Sci U S A (2015) 0.80

Constitutive endocytosis and turnover of the neuronal glycine transporter GlyT2 is dependent on ubiquitination of a C-terminal lysine cluster. PLoS One (2013) 0.80

Reciprocal Phosphorylation and Palmitoylation Control Dopamine Transporter Kinetics. J Biol Chem (2015) 0.79

Striatal dopamine neurotransmission: regulation of release and uptake. Basal Ganglia (2016) 0.79

Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters. Pharmacol Rev (2016) 0.78

The C. elegans model in toxicity testing. J Appl Toxicol (2016) 0.77

Brain slice biotinylation: an ex vivo approach to measure region-specific plasma membrane protein trafficking in adult neurons. J Vis Exp (2014) 0.77

Melittin initiates dopamine transporter internalization and recycling in transfected HEK-293 cells. Eur J Pharmacol (2012) 0.77

Methamphetamine-induced short-term increase and long-term decrease in spatial working memory affects protein Kinase M zeta (PKMζ), dopamine, and glutamate receptors. Front Behav Neurosci (2014) 0.77

Identification of a Vav2-dependent mechanism for GDNF/Ret control of mesolimbic DAT trafficking. Nat Neurosci (2015) 0.77

Classic Studies on the Interaction of Cocaine and the Dopamine Transporter. Clin Psychopharmacol Neurosci (2015) 0.76

Differential Internalization Rates and Postendocytic Sorting of the Norepinephrine and Dopamine Transporters Are Controlled by Structural Elements in the N Termini. J Biol Chem (2016) 0.76

"Slow" Voltage-Dependent Inactivation of CaV2.2 Calcium Channels Is Modulated by the PKC Activator Phorbol 12-Myristate 13-Acetate (PMA). PLoS One (2015) 0.75

Drug inhibition of Gly-Sar uptake and hPepT1 localization using hPepT1-GFP fusion protein. AAPS PharmSci (2001) 0.75

Insights in how amphetamine ROCKs (Rho-associated containing kinase) membrane protein trafficking. Proc Natl Acad Sci U S A (2015) 0.75

Molecular mechanism: the human dopamine transporter histidine 547 regulates basal and HIV-1 Tat protein-inhibited dopamine transport. Sci Rep (2016) 0.75

Ctr9, a Protein in the Transcription Complex Paf1, Regulates Dopamine Transporter Activity at the Plasma Membrane. J Biol Chem (2015) 0.75

The Dopamine Transporter Recycles Via A Retromer-Dependent Post-Endocytic Mechanism: Tracking Studies Using A Novel Fluorophore-Coupling Approach. J Neurosci (2017) 0.75

Articles by these authors

Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature (1982) 6.56

Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature (1983) 5.20

An excitatory amino-acid transporter with properties of a ligand-gated chloride channel. Nature (1995) 4.14

Ion fluxes associated with excitatory amino acid transport. Neuron (1995) 3.76

Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature (1991) 3.46

Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J Neurosci (1994) 3.34

Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol Pharmacol (2001) 3.11

Kinetics of a human glutamate transporter. Neuron (1995) 2.87

Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance. Proc Natl Acad Sci U S A (1997) 2.86

Calcitonin/calcitonin gene-related peptide transcription unit: tissue-specific expression involves selective use of alternative polyadenylation sites. Mol Cell Biol (1984) 2.35

Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants. J Neurosci (1997) 2.35

Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science (1991) 2.13

Alternative RNA processing: determining neuronal phenotype. Science (1984) 1.97

Tissue-specific expression and cDNA cloning of small nuclear ribonucleoprotein-associated polypeptide N. Proc Natl Acad Sci U S A (1988) 1.78

The antidepressant-sensitive dopamine transporter in Drosophila melanogaster: a primordial carrier for catecholamines. Mol Pharmacol (2001) 1.73

Stimulation of noradrenergic sympathetic outflow by calcitonin gene-related peptide. Nature (1983) 1.70

Cloning and expression of a human neutral amino acid transporter with structural similarity to the glutamate transporter gene family. J Biol Chem (1993) 1.66

Expression in brain of a messenger RNA encoding a novel neuropeptide homologous to calcitonin gene-related peptide. Science (1985) 1.60

Vaccinia-T7 RNA polymerase expression system: evaluation for the expression cloning of plasma membrane transporters. Anal Biochem (1991) 1.60

Channels in transporters. Curr Opin Neurobiol (1996) 1.55

Excitatory amino acid transporters: a family in flux. Annu Rev Pharmacol Toxicol (1999) 1.49

A reentrant loop domain in the glutamate carrier EAAT1 participates in substrate binding and translocation. Neuron (1998) 1.39

Sulfhydryl modification of V449C in the glutamate transporter EAAT1 abolishes substrate transport but not the substrate-gated anion conductance. Proc Natl Acad Sci U S A (2001) 1.30

A model for the topology of excitatory amino acid transporters determined by the extracellular accessibility of substituted cysteines. Neuron (2000) 1.29

Differential expression of alpha-CGRP and beta-CGRP by primary sensory neurons and enteric autonomic neurons of the rat. Neuroscience (1988) 1.26

Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor. Biol Psychiatry (2000) 1.25

Selective labeling of neurotransmitter transporters at the cell surface. Methods Enzymol (1998) 1.23

Calcitonin mRNA polymorphism: peptide switching associated with alternative RNA splicing events. Proc Natl Acad Sci U S A (1982) 1.22

cDNA sequence of the rat U snRNP-associated protein N: description of a potential Sm epitope. EMBO J (1989) 1.22

Electrogenic uptake of gamma-aminobutyric acid by a cloned transporter expressed in Xenopus oocytes. J Biol Chem (1992) 1.20

Cell-type-specific expression of catecholamine transporters in the rat brain. J Neurosci (1994) 1.19

Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridinium. Proc Natl Acad Sci U S A (1994) 1.15

Characterization of rat calcitonin mRNA. Proc Natl Acad Sci U S A (1980) 1.15

Constitutive ion fluxes and substrate binding domains of human glutamate transporters. J Biol Chem (1995) 1.14

Distinct proteomic profiles of amphetamine self-administration transitional states. Pharmacogenomics J (2005) 1.12

Activation of protein kinase C inhibits uptake, currents and binding associated with the human dopamine transporter expressed in Xenopus oocytes. J Pharmacol Exp Ther (1997) 1.11

Arachidonic acid elicits a substrate-gated proton current associated with the glutamate transporter EAAT4. Nat Neurosci (1998) 1.11

Excitatory amino acid transporters of the salamander retina: identification, localization, and function. J Neurosci (1998) 1.08

Altered expression of the calcitonin gene associated with RNA polymorphism. Nature (1981) 1.08

Differential modulation of human glutamate transporter subtypes by arachidonic acid. J Biol Chem (1995) 1.06

Functional expression and CNS distribution of a beta-alanine-sensitive neuronal GABA transporter. Neuron (1992) 1.04

Diffuse bipolar cells provide input to OFF parasol ganglion cells in the macaque retina. J Comp Neurol (2000) 1.03

Evaluation of metaiodobenzylguanidine uptake by the norepinephrine, dopamine and serotonin transporters. J Nucl Med (1993) 1.02

Identification of functional domains of the human glutamate transporters EAAT1 and EAAT2. J Biol Chem (1998) 1.00

Effects of threo-beta-hydroxyaspartate derivatives on excitatory amino acid transporters (EAAT4 and EAAT5). J Neurochem (2001) 0.99

Structural domains of catecholamine transporter chimeras involved in selective inhibition by antidepressants and psychomotor stimulants. Mol Pharmacol (1995) 0.98

Functional diversity of excitatory amino acid transporters: ion channel and transport modes. Am J Physiol (1999) 0.98

Calcitonin gene-related peptide messenger RNA is expressed in sensory neurones of the dorsal root ganglia and also in spinal motoneurones in man and rat. Neurosci Lett (1988) 0.97

Transmembrane topology mapping using biotin-containing sulfhydryl reagents. Methods Enzymol (1998) 0.97

Differentiation of substrate and nonsubstrate inhibitors of the high-affinity, sodium-dependent glutamate transporters. Mol Pharmacol (1999) 0.94

Neurotransmitter transporters. A tale of two families. Nature (1992) 0.94

Identification of the putative cell-free translation product of rat calcitonin mRNA. J Biol Chem (1980) 0.92

The dopamine transporter in mesencephalic cultures is refractory to physiological changes in membrane voltage. J Neurosci (2001) 0.92

Arachidonic acid stimulates a novel cocaine-sensitive cation conductance associated with the human dopamine transporter. J Neurosci (2000) 0.90

Identification and characterization of a cDNA encoding a neuronal glutamate transporter from Drosophila melanogaster. Receptors Channels (1998) 0.89

N-linked oligosaccharides are required for cell surface expression of the norepinephrine transporter but do not influence substrate or inhibitor recognition. J Neurochem (1996) 0.89

Peptide diversity from exon choice: RNA processing regulation in the neuroendocrine system. Mol Cell Endocrinol (1985) 0.86

Autocrine regulation of norepinephrine transporter expression. Mol Cell Neurosci (2001) 0.85

Calcitonin, prolactin, and growth hormone gene expression as model systems for the characterization of neuroendocrine regulation. Recent Prog Horm Res (1983) 0.85

Vaccinia virus-T7 RNA polymerase expression system for neurotransmitter transporters. Methods Enzymol (1998) 0.84

Stable expression of a neuronal gamma-aminobutyric acid transporter, GAT-3, in mammalian cells demonstrates unique pharmacological properties and ion dependence. Mol Pharmacol (1994) 0.84

The mouse and human excitatory amino acid transporter gene (EAAT1) maps to mouse chromosome 15 and a region of syntenic homology on human chromosome 5. Genomics (1994) 0.82

Localization and function of five glutamate transporters cloned from the salamander retina. Vision Res (1998) 0.82

Mouse excitatory amino acid transporter EAAT2: isolation, characterization, and proximity to neuroexcitability loci on mouse chromosome 2. Genomics (1994) 0.82

Amino acid neurotransmitter transporters: structure, function, and molecular diversity. Bioessays (1993) 0.81

Expression of neurotransmitter transport from rat brain mRNA in Xenopus laevis oocytes. Proc Natl Acad Sci U S A (1988) 0.80

Families of twelve transmembrane domain transporters. Curr Opin Biotechnol (1992) 0.79

GABA and glutamate transporters: therapeutic and etiologic implications for epilepsy. Adv Neurol (1999) 0.79

Calcitonin COOH-terminal cleavage peptide as a model for identification of novel neuropeptides predicted by recombinant DNA analysis. J Biol Chem (1982) 0.78

RNA processing regulation of neuroendorcrine gene expression. DNA (1982) 0.78

Localization of immunoreactivity for calcitonin gene-related peptide in the rat anterior pituitary during ontogeny and gonadal steroid manipulations and detection of its messenger ribonucleic acid. Endocrinology (1990) 0.78

Molecular mechanisms of cell-specific and regulated expression of the calcitonin/alpha-CGRP and beta-CGRP genes. Ann N Y Acad Sci (1992) 0.77

Localization of calcitonin gene-related peptide in the rat and human pituitary gland using immunocytochemistry and in situ hybridization. CGRP expression during ontogeny and after endocrine manipulations. Ann N Y Acad Sci (1992) 0.76

Distinct, developmentally regulated brain mRNAs direct the synthesis of neurotransmitter transporters. J Neurochem (1991) 0.75

A device to rapidly core out tissue culture plates for autoradiographic visualization of cells transfected with cDNA libraries. Biotechniques (1990) 0.75

In vivo generation of chimeras. Methods Enzymol (1998) 0.75

Alternative RNA processing events as a critical developmental regulatory strategy in neuroendocrine gene expression. Biochem Soc Symp (1984) 0.75

Discrete structural domains and cell-specific expression determine functional selectivity of the dopamine and norepinephrine transporters. NIDA Res Monogr (1996) 0.75